Technical Analysis for MNK - Mallinckrodt plc

Grade Last Price % Change Price Change
F 7.74 -1.53% -0.12
MNK closed down 1.53 percent on Thursday, January 26, 2023, on 47 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Flat

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Outside Day Range Expansion 0.00%
Bullish Engulfing Bullish -1.53%
Crossed Above 20 DMA Bullish -1.53%
Hammer Candlestick Bullish 0.00%
20 DMA Resistance Bearish 0.52%
Doji - Bullish? Reversal 0.52%
Outside Day Range Expansion 0.52%
NR7 Range Contraction 0.26%
NR7-2 Range Contraction 0.26%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Outside Day about 11 hours ago
Down 3% about 11 hours ago
Fell Below Previous Day's Low about 11 hours ago
Down 2 % about 11 hours ago
Fell Below 20 DMA about 11 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mallinckrodt plc Description

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Immunotherapy Pharmaceutical Products Inflammatory Diseases Rheumatoid Arthritis Multiple Sclerosis Active Pharmaceutical Ingredients Burns Respiratory Therapist Constipation Gastrointestinal Products Hepatorenal Syndrome Systemic Lupus Erythematosus Treatment Of Hepatorenal Syndrome Amitiza Terlipressin

Is MNK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.1
52 Week Low 7.38
Average Volume 83,255
200-Day Moving Average 0.00
50-Day Moving Average 9.28
20-Day Moving Average 7.80
10-Day Moving Average 7.77
Average True Range 0.48
RSI 33.77
ADX 28.59
+DI 16.69
-DI 17.60
Chandelier Exit (Long, 3 ATRs) 7.47
Chandelier Exit (Short, 3 ATRs) 8.83
Upper Bollinger Bands 8.10
Lower Bollinger Band 7.50
Percent B (%b) 0.4
BandWidth 7.69
MACD Line -0.48
MACD Signal Line -0.62
MACD Histogram 0.1384
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.40
Resistance 3 (R3) 8.41 8.21 8.29
Resistance 2 (R2) 8.21 8.04 8.20 8.25
Resistance 1 (R1) 7.97 7.93 7.87 7.96 8.22
Pivot Point 7.77 7.77 7.72 7.76 7.77
Support 1 (S1) 7.53 7.60 7.43 7.52 7.26
Support 2 (S2) 7.33 7.49 7.32 7.23
Support 3 (S3) 7.09 7.33 7.19
Support 4 (S4) 7.08